Nivolumab plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastroesophageal junction cancer-regional differences in efficacy.
Editorial Article
Overview
publication date
- October 17, 2022
published in
- Annals of palliative medicine Journal
Research
keywords
- Esophageal Neoplasms
- Stomach Neoplasms
Identity
Scopus Document Identifier
- 85140735504
Digital Object Identifier (DOI)
- 10.21037/apm-22-851
PubMed ID
- 36267012
Additional Document Info
volume
- 11
issue
- 10